Table 1.

In vivo concentration ranges of the study compounds.

Name of compound	Molecular weight	Concentration use in this study		In vivo Cmax		Dose	Subjects	N	Reference
	g/mol	μg/mL	μM	μg/mL	μM
Aripiprazole	448.39	10.00	22.30	0.14	0.31	P.O. 10 mg/day tablets	Healthy subjects	24	[17]
Ziprasidone	412.94	10.00	24.22	0.09	0.22	P.O. 40 mg tablets	Healthy subjects	10	[18]
CBN	310.43	10.00	32.21	0.01	0.02	Case report	–	–	[19]
THC	314.45	10.00	31.80	1.10	3.50	Case report	–	–	[19]
CBD	314.47	10.00	31.80	1.39	4.40	P.O. 1500 mg CBD twice daily	Healthy subjects	9	[20]
Dexamethasone	392.46	10.00	25.48	0.26	0.66	P.O. 20 mg tablet under fasting conditions	Healthy subjects	34	[21]
Trimethoprim	290.32	10.00	34.44	2.70	9.30	P.O. 400:2000 mg trimethoprim: sulfamethoxazole	Healthy subjects	24	[22]
Ivermectin	875.10	10.00	11.43	0.08	0.09	P.O. 12 mg solution	Healthy subjects	11	[23]
Azithromycin	749.00	10.00	13.35	0.40	0.53	P.O. 500 mg	Healthy subjects	12	[24,25]
Clarithromycin	747.95	10.00	13.37	2.85	3.81	P.O. 500 mg	Healthy subjects	17	[26]
Ciprofloxacin	331.35	10.00	30.18	1.10	3.32	P.O. 200 mg	Healthy subjects	12	[27]
Erythromycin	733.93	10.00	13.63	3.49	4.75	P.O. 800 mg every 12 h for 3 doses	Healthy subjects	23	[28]
Roxithromycin	837.05	10.00	11.95	9.70	11.59	P.O. 300 mg	Healthy subjects	20	[29]
Vancomycin	1449.30	10.00	6.90	10.00	6.90	I.V. 10 mg/kg	Patients	6	[30]
Hydroxychloroquine	335.87	10.00	29.77	3.30	9.83	I.V. 310 mg over 0.5 h	Healthy subjects	4	[31]